A detailed history of Janus Henderson Group PLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 13,024 shares of MORF stock, worth $443,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,024
Previous 13,024 -0.0%
Holding current value
$443,727
Previous $376,000 21.81%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$19.95 - $31.0 $438 - $682
-22 Reduced 0.17%
13,024 $376,000
Q3 2023

Nov 14, 2023

SELL
$21.33 - $59.42 $3.04 Million - $8.47 Million
-142,571 Reduced 91.62%
13,046 $298,000
Q2 2023

Aug 14, 2023

SELL
$34.33 - $62.11 $1.55 Million - $2.8 Million
-45,019 Reduced 22.44%
155,617 $8.92 Million
Q1 2023

May 15, 2023

BUY
$26.01 - $48.69 $5.22 Million - $9.77 Million
200,636 New
200,636 $7.55 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.